NCT00344942View on ClinicalTrials.gov

Efficacy and Safety Study of Nasacort in Chronic Non Allergic and Non Infectious Rhinitis in Adults

PHASE3TerminatedINTERVENTIONAL

Enrollment

77

Participants

Timeline

Start Date

April 30, 2006

Primary Completion Date

April 30, 2007

Conditions

Rhinitis

Interventions

DRUG

triamcinolone acetonide

220µg/day or a double spray into each nostril once daily for 12 weeks'treatment

DRUG

placebo

a double spray into each nostril once daily

Trial Locations (1)

Unknown

Sanofi-Aventis, Paris

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Sanofi

INDUSTRY